Bleakley Financial Group LLC Has $919,000 Stock Position in Huron Consulting Group Inc. (NASDAQ:HURN)

Bleakley Financial Group LLC raised its position in Huron Consulting Group Inc. (NASDAQ:HURN) by 42.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,452 shares of the business services provider’s stock after buying an additional 2,524 shares during the period. Bleakley Financial Group LLC’s holdings in Huron Consulting Group were worth $919,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Covestor Ltd boosted its holdings in shares of Huron Consulting Group by 26,500.0% in the 1st quarter. Covestor Ltd now owns 266 shares of the business services provider’s stock worth $26,000 after acquiring an additional 265 shares in the last quarter. Ashton Thomas Private Wealth LLC bought a new stake in shares of Huron Consulting Group during the second quarter worth $28,000. Daiwa Securities Group Inc. raised its holdings in shares of Huron Consulting Group by 800.0% in the first quarter. Daiwa Securities Group Inc. now owns 1,800 shares of the business services provider’s stock valued at $174,000 after buying an additional 1,600 shares during the last quarter. Dakota Wealth Management bought a new position in shares of Huron Consulting Group in the second quarter valued at about $219,000. Finally, PNC Financial Services Group Inc. lifted its position in Huron Consulting Group by 39.5% during the 4th quarter. PNC Financial Services Group Inc. now owns 2,555 shares of the business services provider’s stock worth $263,000 after buying an additional 724 shares in the last quarter. 93.90% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

HURN has been the subject of a number of research analyst reports. StockNews.com raised shares of Huron Consulting Group from a “sell” rating to a “hold” rating in a research note on Saturday, August 3rd. Benchmark reaffirmed a “buy” rating and set a $140.00 price objective on shares of Huron Consulting Group in a report on Wednesday, July 31st. Finally, Barrington Research reiterated an “outperform” rating and issued a $137.00 price objective on shares of Huron Consulting Group in a research report on Monday, September 9th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $131.75.

Insider Buying and Selling

In other Huron Consulting Group news, insider Kyle Featherstone sold 820 shares of the company’s stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $108.07, for a total value of $88,617.40. Following the completion of the sale, the insider now owns 1,565 shares of the company’s stock, valued at approximately $169,129.55. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other Huron Consulting Group news, CEO C. Mark Hussey sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, August 12th. The shares were sold at an average price of $103.13, for a total transaction of $412,520.00. Following the sale, the chief executive officer now directly owns 81,081 shares in the company, valued at approximately $8,361,883.53. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Kyle Featherstone sold 820 shares of Huron Consulting Group stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $108.07, for a total transaction of $88,617.40. Following the completion of the transaction, the insider now directly owns 1,565 shares in the company, valued at approximately $169,129.55. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 11,168 shares of company stock valued at $1,170,515 in the last 90 days. 2.02% of the stock is owned by insiders.

Huron Consulting Group Stock Performance

Shares of Huron Consulting Group stock opened at $108.03 on Monday. The firm has a fifty day moving average of $106.92 and a two-hundred day moving average of $99.87. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.93 and a current ratio of 1.93. The stock has a market capitalization of $1.95 billion, a price-to-earnings ratio of 31.13 and a beta of 0.61. Huron Consulting Group Inc. has a 52 week low of $84.26 and a 52 week high of $115.65.

Huron Consulting Group (NASDAQ:HURN) last released its earnings results on Tuesday, July 30th. The business services provider reported $1.68 earnings per share for the quarter, beating the consensus estimate of $1.48 by $0.20. The firm had revenue of $371.70 million for the quarter, compared to analyst estimates of $374.33 million. Huron Consulting Group had a return on equity of 20.44% and a net margin of 5.46%. The company’s quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.38 earnings per share. As a group, equities research analysts predict that Huron Consulting Group Inc. will post 5.95 EPS for the current year.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.